Lakewood-Amedex Biotherapeutics, Inc. (LABT)
0.2359
-0.05
(-17.23%)
USD |
NASDAQ |
Oct 29, 16:00
0.2239
-0.01
(-5.09%)
After-Hours: 20:00
Lakewood-Amedex Biotherapeutics EPS Diluted (Quarterly) : -1.739 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.739 |
| March 31, 2026 | -2.00 |
| December 31, 2025 | -3.90 |
| September 30, 2025 | -2.70 |
| June 30, 2025 | -0.20 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.10 |
| December 31, 2024 | -1.20 |
| September 30, 2024 | -2.80 |
| June 30, 2024 | -0.30 |
| March 31, 2024 | -0.20 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.772M |
| Total Expenses (Quarterly) | 3.772M |
| Enterprise Value | -3.865M |
| Earnings Yield | -4.38K% |